Acute heart failure

Pradeep P.A. Mammen, William K. Cornwell, Mark P. Birkenbach, Daniel J. Garry

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart failure affects more than six million people in the United States, or 2 % of the population. It exacts a toll on people's health and lives, as well as economically. Most heart failure patients experience at least one episode of acute decompensated heart failure (ADHF) resulting in an emergency room visit or hospital stay. This chapter focuses on the epidemiology, pathophysiology, diagnostic assessment, and clinical management of patients who have heart failure with reduced ejection fraction (HFrEF) and who present to the hospital with ADHF. To guide clinicians in managing acute heart failure, hospitalized patients are typically assigned a hemodynamic profile to determine the degree of hemodynamic compromise, which is useful for tailoring treatment regimens. Other topics addressed in this chapter include the importance of biomarkers, namely, natriuretic peptides and cardiac troponins that help with diagnosis, response to therapy, and prognosis; the profile of patients at higher risk for structural complications following myocardial infarction; the use of beta blockers, angiotensin-converting enzyme (ACE) inhibitors, aldosterone receptor antagonists, and diuretics in medical management; and the benefits and risks of mechanical circulatory support for decompensated heart failure.

Original languageEnglish (US)
Title of host publicationCongestive Heart Failure and Cardiac Transplantation
Subtitle of host publicationClinical, Pathology, Imaging and Molecular Profiles
PublisherSpringer International Publishing
Pages105-117
Number of pages13
ISBN (Electronic)9783319445779
ISBN (Print)9783319445755
DOIs
StatePublished - Jun 1 2017

Fingerprint

Heart Failure
Hemodynamics
Mineralocorticoid Receptor Antagonists
Natriuretic Peptides
Troponin
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Hospital Emergency Service
Length of Stay
Epidemiology
Biomarkers
Myocardial Infarction
Health
Therapeutics
Population

Keywords

  • Acute decompensated heart failure
  • Cardiac troponins
  • Heart failure
  • Heart failure classification
  • HFrEF
  • Mechanical circulatory support
  • Myocarditis
  • Natriuretic peptides
  • STEMI
  • Stevenson Hemodynamic Profile

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mammen, P. P. A., Cornwell, W. K., Birkenbach, M. P., & Garry, D. J. (2017). Acute heart failure. In Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles (pp. 105-117). Springer International Publishing. https://doi.org/10.1007/978-3-319-44577-9_7

Acute heart failure. / Mammen, Pradeep P.A.; Cornwell, William K.; Birkenbach, Mark P.; Garry, Daniel J.

Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles. Springer International Publishing, 2017. p. 105-117.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mammen, PPA, Cornwell, WK, Birkenbach, MP & Garry, DJ 2017, Acute heart failure. in Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles. Springer International Publishing, pp. 105-117. https://doi.org/10.1007/978-3-319-44577-9_7
Mammen PPA, Cornwell WK, Birkenbach MP, Garry DJ. Acute heart failure. In Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles. Springer International Publishing. 2017. p. 105-117 https://doi.org/10.1007/978-3-319-44577-9_7
Mammen, Pradeep P.A. ; Cornwell, William K. ; Birkenbach, Mark P. ; Garry, Daniel J. / Acute heart failure. Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles. Springer International Publishing, 2017. pp. 105-117
@inbook{2d06a2391cdf417c9ee020430dcd3225,
title = "Acute heart failure",
abstract = "Heart failure affects more than six million people in the United States, or 2 {\%} of the population. It exacts a toll on people's health and lives, as well as economically. Most heart failure patients experience at least one episode of acute decompensated heart failure (ADHF) resulting in an emergency room visit or hospital stay. This chapter focuses on the epidemiology, pathophysiology, diagnostic assessment, and clinical management of patients who have heart failure with reduced ejection fraction (HFrEF) and who present to the hospital with ADHF. To guide clinicians in managing acute heart failure, hospitalized patients are typically assigned a hemodynamic profile to determine the degree of hemodynamic compromise, which is useful for tailoring treatment regimens. Other topics addressed in this chapter include the importance of biomarkers, namely, natriuretic peptides and cardiac troponins that help with diagnosis, response to therapy, and prognosis; the profile of patients at higher risk for structural complications following myocardial infarction; the use of beta blockers, angiotensin-converting enzyme (ACE) inhibitors, aldosterone receptor antagonists, and diuretics in medical management; and the benefits and risks of mechanical circulatory support for decompensated heart failure.",
keywords = "Acute decompensated heart failure, Cardiac troponins, Heart failure, Heart failure classification, HFrEF, Mechanical circulatory support, Myocarditis, Natriuretic peptides, STEMI, Stevenson Hemodynamic Profile",
author = "Mammen, {Pradeep P.A.} and Cornwell, {William K.} and Birkenbach, {Mark P.} and Garry, {Daniel J.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/978-3-319-44577-9_7",
language = "English (US)",
isbn = "9783319445755",
pages = "105--117",
booktitle = "Congestive Heart Failure and Cardiac Transplantation",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Acute heart failure

AU - Mammen, Pradeep P.A.

AU - Cornwell, William K.

AU - Birkenbach, Mark P.

AU - Garry, Daniel J.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Heart failure affects more than six million people in the United States, or 2 % of the population. It exacts a toll on people's health and lives, as well as economically. Most heart failure patients experience at least one episode of acute decompensated heart failure (ADHF) resulting in an emergency room visit or hospital stay. This chapter focuses on the epidemiology, pathophysiology, diagnostic assessment, and clinical management of patients who have heart failure with reduced ejection fraction (HFrEF) and who present to the hospital with ADHF. To guide clinicians in managing acute heart failure, hospitalized patients are typically assigned a hemodynamic profile to determine the degree of hemodynamic compromise, which is useful for tailoring treatment regimens. Other topics addressed in this chapter include the importance of biomarkers, namely, natriuretic peptides and cardiac troponins that help with diagnosis, response to therapy, and prognosis; the profile of patients at higher risk for structural complications following myocardial infarction; the use of beta blockers, angiotensin-converting enzyme (ACE) inhibitors, aldosterone receptor antagonists, and diuretics in medical management; and the benefits and risks of mechanical circulatory support for decompensated heart failure.

AB - Heart failure affects more than six million people in the United States, or 2 % of the population. It exacts a toll on people's health and lives, as well as economically. Most heart failure patients experience at least one episode of acute decompensated heart failure (ADHF) resulting in an emergency room visit or hospital stay. This chapter focuses on the epidemiology, pathophysiology, diagnostic assessment, and clinical management of patients who have heart failure with reduced ejection fraction (HFrEF) and who present to the hospital with ADHF. To guide clinicians in managing acute heart failure, hospitalized patients are typically assigned a hemodynamic profile to determine the degree of hemodynamic compromise, which is useful for tailoring treatment regimens. Other topics addressed in this chapter include the importance of biomarkers, namely, natriuretic peptides and cardiac troponins that help with diagnosis, response to therapy, and prognosis; the profile of patients at higher risk for structural complications following myocardial infarction; the use of beta blockers, angiotensin-converting enzyme (ACE) inhibitors, aldosterone receptor antagonists, and diuretics in medical management; and the benefits and risks of mechanical circulatory support for decompensated heart failure.

KW - Acute decompensated heart failure

KW - Cardiac troponins

KW - Heart failure

KW - Heart failure classification

KW - HFrEF

KW - Mechanical circulatory support

KW - Myocarditis

KW - Natriuretic peptides

KW - STEMI

KW - Stevenson Hemodynamic Profile

UR - http://www.scopus.com/inward/record.url?scp=85054698811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054698811&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-44577-9_7

DO - 10.1007/978-3-319-44577-9_7

M3 - Chapter

AN - SCOPUS:85054698811

SN - 9783319445755

SP - 105

EP - 117

BT - Congestive Heart Failure and Cardiac Transplantation

PB - Springer International Publishing

ER -